July 25, 2014 1:11 PM ET

Capital Markets

Company Overview of Versant Venture Capital III, L.P.

Company Overview

Versant Venture Capital III, L.P. specializes in incubation, seed, start-ups, and early venture. It seeks to invest in healthcare and life sciences companies. The fund makes investments across the entire spectrum of the life sciences venture space, investing roughly similar amounts in drug development opportunities and medical device companies, with less attention paid to health care service. It prefers to invest around $10 million over the life of an investment. Versant Venture Capital III, L.P. is comprised of parallel fund Versant Side Fund III, L.P.

3000 Sand Hill Road

Building 4

Suite 210

Menlo Park, CA 94025

United States

Founded in 2005

Phone:

650-233-7877

Fax:

650-854-9513

Key Executives for Versant Venture Capital III, L.P.

Managing Director
Managing Director
Age: 59
Managing Director
Managing Director
Age: 61
Co-Founder and Managing Director
Age: 68
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Roan Capital Partners LP United States
Wall Street Strategies, Inc. United States
Noble China Holdings Ltd. United States
North Sea Partners LLC United States
GCA II Acquisition Corp. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
July 30, 2013
Trius Therapeutics, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Versant Venture Capital III, L.P., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.